Partners
Diamond
GSK
GSK is a global biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
We are a focused biopharma company. We prevent and treat disease with specialty medicines, vaccines and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas – respiratory, immunology and inflammation; oncology; HIV and infectious diseases – to impact health at scale. Our Ahead Together strategy means intervening early to prevent and change the course of disease, helping to protect people and support healthcare systems. For more information, please visit: https://www.gsk.com/en-gb/locations/saudi-arabia/
Boehringer Ingelheim
Improving the health and lives of humans and animals is the goal of the research-driven biopharmaceutical company Boehringer Ingelheim. The focus is on diseases in areas with a high unmet medical need. The company therefore concentrates on developing innovative therapies that can improve and extend lives.
Family-owned since its foundation in 1885, Boehringer Ingelheim is one of the top 20 companies in the pharmaceutical industry. Our aim is to transform the lives of patients – across generations. This goal inspires all of our over 53,000 employees who create value through innovation.
Boehringer Ingelheim is active in the research areas of cardiometabolic diseases, oncology, respiratory diseases, immunology, diseases of the central nervous system and retinal health, The company spent some 5.0 billion euros on research and development worldwide in 2022, with research and development expenses on human pharma alone accounting for 24.8 percent of net sales generated in this area. The global research network for human pharmaceuticals includes facilities in Germany (Biberach and Ochsenhausen), the USA (Ridgefield), Austria (Vienna and Innsbruck), Japan (Kobe) and Switzerland (Basel and Geneva). To learn more, visit: https://www.boehringer-ingelheim.com/mea
Platinum
AstraZeneca
We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally.
We have three priorities designed to deliver our growth through innovation strategy.
Accelerate Innovative Science:
Accelerating the next wave of new molecular entities, building our capabilities in immunology and rare diseases, pursuing new scientific modalities and driving R&D productivity
Deliver Growth and Therapy Area Leadership:
Meeting our growth and profitability goals through successful innovation and commercial excellence, as well as completing the Alexion acquisition
Be a Great Place to Work:
Contributing to the enterprise and to society, with a focus on inclusion and diversity, lifelong learning, improving access to healthcare, environmental protection, and ethics and transparency, as well as delivering our Ambition Zero Carbon program.
Inspired by our Values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society.
We are committed to operating in a way that recognizes the interconnection between business growth, the needs of society and the limitations of our planet.
For more information, please visit:https://www.astrazeneca.com/country-sites/saudi-arabia.html
Gold
Roche Products Saudi Arabia LLC.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit: https://www.Roche.com
Pfizer Saudi
Pfizer is a global biopharmaceutical and research company that has contributed to the discovery, development, and manufacturing of healthcare products, including medicines and vaccines to create breakthroughs to change patients’ lives. Pfizer has been present in Saudi Arabia since the early 1960s, aiming to provide high-quality medicines, enhance health, raise awareness of various diseases and therapeutic areas, and offer preventive solutions in partnership with governmental sectors and private healthcare institutions.
Pfizer Saudi is one of the first pharmaceutical companies to obtain a commercial license from the Saudi Arabian General Investment Authority (currently the Ministry of Investment). The company opened its factory in King Abdullah Economic City in 2017, where some of Pfizer’s products are manufactured locally. Pfizer Saudi seeks to attract national competencies to help contribute to the development of the pharmaceutical sector, in line with the Kingdom’s Vision 2030. For more information, please visit: www.pfizer.sa
Silver
Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.
We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. For more information, please visit: https://www.campus.sanofi
Contributors
Sudair Pharmaceutical Company
Sudair Pharmaceutical Company (SPC) is a limited liability Saudi company, established in 2014 in order to build an “Advanced Pharmaceutical Industrial Complex” to fulfil the unmet in the pharmaceutical market with a Vision to improve lives through localizing advanced therapies by increasing the accessibility of high-quality medicinal products, building a professional team to localize and develop a cutting-edge manufacturing technologies.
Sudair Pharma started its mission in KSA & GCC market through building the 1st manufacturing facility in the region dedicated for anti-neoplastic agents (oral & IV) then we expanded our portfolio through building a dedicated site for specialized products that cover different therapy areas like Multiple Sclerosis, Neurology, Anti-coagulation & Pulmonary Hypertension in addition to a wide portfolio for Asthma and CODP management.
For more information, please visit: https://sudairpharma.com/
Bayer
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. An analysis by well-known branding agency Interbrand in 2015 valued the Bayer brand at €6.3 billion. A growing and aging world population requires an adequate supply of food and improved medical care.
With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.
Our goal is to create value for our customers, stockholders and employees, while also strengthening the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities. Employees with a passion for innovation enjoy excellent development opportunities at Bayer. All this goes to make up our purpose: Science for a better life. For more information, please visit: www.bayer.com
Alkawader Scientific Company
Alkawader Scientific Company for Medical Supplies, a limited liability company, was established as part of Bahammam group seven years ago. Our vision is “to contribute to a future of a high-quality medical care for patients and professionals” while our mission is “Providing and supporting high-quality medical technologies through unique partnerships”. We take pride in our ability to provide high-tech support and expertise required by today’s market. We focus on unique state-of-the-art technologies and therapies which add new tools for diagnoses and therapies. We currently work in the fields of bronchoscopic navigation, emphysema thermal ablation, MRI-safe prostate biopsy and ablation robotics, vestibular/balance diagnoses and treatments, ribcage reconstruction and pectus correction surgery, and modern sterilization technologies. We also have been supplying state-of-the-art breathing masks and chest drainage systems. We are excited to launch Hayek Biphasic Cuirass Ventilation soon which simulates natural airway-free breathing. For more information, please contact us on: info@kawader-med.com
Exhibitors
Biologix
Biologix helps multinational pharmaceutical manufacturers bring innovative drugs to market in the MENA region. Positioned across 17+ key strategic locations in the GCC, Egypt, North Africa and the Levant, we are pioneers in regional distribution and promotion of innovative products and solutions for difficult-to-treat diseases.
A privately owned pharmaceutical company organized under the laws of UAE, Biologix provides end-to-end solutions from the preregistration phase all the way to commercial-scale market access and risk management including: Named patient supply, Pharmaceutical registration, Awareness and promotional campaigns, Cold chain distribution, Tender and risk management, and Pharmacovigilance and product safety.
Incorporated in the Dubai Airport Free Zone in September 2002, Biologix traces its history back to 1997. We were among the first organizations to recognize the need for long-term strategic partnerships in the MENA region, and today we connect pharma leaders around the world with integrated direct-access healthcare approaches. To learn more, visit: https://biologixpharma.com
EVA Pharma for Industry
EVA Pharma for Industry is a subsidiary of EVA Pharma Holdings, one of the fastest-growing healthcare companies in the Middle East and Africa. EVA Pharma for Industry is registered in the Kingdom of Saudi Arabia as a local pharmaceutical manufacturer with a focus on sustainability and local investment in the Kingdom.
EVA Pharma empowers the fight for health and well-being in communities around the world. With a 5,000-strong team of professionals in 40+ countries, the company produces more than one million healthcare products a day at its state-of-the-art manufacturing facilities, which are equipped with cutting-edge technology, are internationally recognized for innovation, and have been approved by multiple regulatory agencies.
The company’s product portfolio focuses on pressing, yet unmet, disease areas, such as diabetes and cardiovascular diseases, oncology, neuroscience, ophthalmology, anti-infectives, bone and pain, hepatology, and reproductive health, to meet both local and international demand. For more information, please visit: www.evapharma.com/en-SA
Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.
We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. For more information, please visit: https://www.campus.sanofi
Hikma
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we are helping to shape a healthier world that enriches all our communities. We do this by living our culture, delivering our strategy, and acting responsibly.
We are a trusted, reliable partner and dependable source of over 760+ (as of 31 December 2022) high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe.
We are a global business with 32 manufacturing plants and 8 R&D centres. We are a global company with a local presence in KSA since 1998 and we are producing high quality medicines and making them accessible to the people who need them through our three specialised plants, the general formulation plant, penicillin plant and cephalosporin plant in Riyadh. To learn more, visit: https://www.hikma.com/home/
taiba rare
Established in 1980, taiba was the first company in providing medicines for rare diseases in the Middle East. Today, we are the leading company in rare diseases with a diverse, innovative portfolio. Reflecting our commitment to patients, we continue to focus on access to health for patients in our region to reach those in need of our medicines through partnerships. We have the ability and the responsibility to ensure access to medicines through alliances with research and development companies.
Mission:
We strive to transform and save patients’ lives affected by rare diseases in the Middle East and African region by providing innovative medicines and creating meaningful value in all what we do.
Vision:
Our ambition to be the regional reference in orphan drugs, dedicated to providing innovative solutions for unmet medical needs of rare diseases today and in the future.
To learn more, visit: www.taibarare.com
Gulf Medical Company
Our Mission is to provide state of the art technology and solutions to the healthcare industry in Saudi Arabia and the GCC, and work closely with medical practitioners to contribute to patient care. To play an active role in developing skills of healthcare providers with the support of our suppliers. To evaluate market needs, adapt to changing demands, and continuously enrich our portfolio to effectively focus corporate assets in the service of various disciplines, thus enabling healthy growth. To continue our commitment to offer premium and unique services and ensure ultimate levels of customer satisfaction by recruiting, developing, motivating, and rewarding highly qualified personnel who demonstrate exceptional levels of professionalism and dedication. We believe that making a sale is not the end, but the beginning of a long-lasting relationship which is prized above all. For more information, please visit our website: www.gulfmedical.com
Vitalograph
Vitalograph is a global leading provider of respiratory diagnostic solutions. Through the delivery of solutions that are accurate and reliable, healthcare professionals are empowered to give the best possible respiratory care to their patients, wherever it is needed.
Vitalograph has recently launched VitaloPFT, its highly anticipated pulmonary function testing range, aimed for use in secondary care. The VitaloPFT series delivers advanced respiratory diagnostic solutions to hospitals and other secondary care units that demand complex pulmonary function testing. Renowned for its highly accurate and reliable spirometry solutions, Vitalograph’s latest addition embodies the company’s advanced respiratory diagnostics expertise and delivers versatility and value to healthcare providers. The addition of the VitaloPFT series means that Vitalograph is the manufacturer with the largest array of respiratory diagnostic solutions in the world.
All of Vitalograph’s respiratory diagnostic solutions are designed to be used with highly effective bacterial viral filters (BVF™), which keep cross-contamination to a minimum during testing, protecting both patient and healthcare provider. Vitalograph’s main R&D and manufacturing operations are located in its Irish base, in County Clare. To learn more, visit: vitalograph.com
Abdulrehman Algosaibi CO. L.L.C
Quite some time back, when the Kingdom was just a couple decades old, the Ministry of Health sensed the need for developing a Kingdom-wide healthcare system which would dramatically improve the welfare of its citizens. One of their first decisions was to build ten hospitals at the same time, at various locations. That decision was effectively the dawn of the Medical & Scientific service in Saudi Arabia. That very event also turned out to be a major milestone for us, a corner stone of what Algosaibi is today.
Established in 1944, Abdulrehman Algosaibi GTC put in a bid for furnishing and equipping those hospitals with the help of N.V. Philip of Holland. We won that tender, and not only we successfully equipped and furnished the first ten hospitals in Saudi Arabia, we as well learned a lot – from international sourcing practice, dealing with reputable companies, to good planning, logistics, distribution, and execution.
Since that time, the Medical and health care industry in Saudi Arabia has grown and matured, and we with it. Other than our initial range of furnishings and equipment, we have added pharmaceutical, vaccines and veterinary products.
Abdulrehman Algosaibi GTC as a company certified to both ISO 9001:2015 and BS EN ISO 1348:2016 is well known for its contribution to the Healthcare services in Saudi Arabia as leading Distributor in the healthcare field. We represent more than 125 major principals of Medical & Scientific Equipment, Hospital Supplies, Pharmaceuticals, Dental and Veterinary products from around the world. We have achieved the distinction of being amongst the Top 100 Companies in Saudi Arabia and the Top 100 Companies in the Gulf region. In 1997, we also qualified as one of the Top 10 Trading Companies in Saudi Arabia.
Currently our business is based on four key Business Operations namely Pharma and Biological Operations, Medical & Scientific Operations and Veterinary Division, each a specialized in providing a range of products and services. To learn more about Abdulrehman Algosaibi GTC please visit: aralgosaibico.com
NOVARTIS
NOVARTIS is a leading global pharmaceutical company reimagining medicine to improve people’s lives. We are committed to Saudi society to continue support national health care system with innovative medicines, improve patient access and contribute to National Transformation Plan and Saudi vision 2030.
Novartis worked out a comprehensive localization plan that addresses many economic as well as other transformation measures that go with the government plans like localization of work forces, technology transfers, R&D, support different national healthcare programs and access to innovation.
Novartis had chosen KSA to be one of the first group of worldwide markets to implement cell & gene technologies. For that, we are committed to work with our partners in Saudi Arabia who are among the best health care providers & centers to establish the infrastructure, human capabilities, regulatory environment and technology transfer of this era. Our effort up-to-date made an excellent achievement where on November 2019, the first injected patient of gene therapy outside EU and US was in Saudi Arabia. We are proud of making this for the first time because of collaboration and support of different Saudi government agencies and institutions. For more information, please visit: https://www.novartis.com/sa-ar/
Supporters +
Trans-Mediterranean Co
Founded in 2015 with a vision to be one of the leaders in healthcare market in Saudi Arabia by delivering high-quality products and services. Our company has built a strong reputation for reliability and quality by partnering with several esteemed international medical equipment manufacturers and premium customers.
Through strategic collaborations and a skilled workforce, TMT is dedicated to enhancing healthcare delivery kingdom wide through its branches. We are specialized in Respiratory devises and proud to go hand by hand with the leaders in this field. MIR (Medical International Research Co.), the world leading company in Spirometry that provides a wide range of Spirometry devices covering different segments with a unique technologies and smart devices for remote patient monitoring. Geratherm-Respiratory for PFT and Bodybox with German technology and Seoil Pacific Co., specialized in cough assist device (comfort cough).
For mor information, please visit: www.tmt.com.sa
